Alcon (ALC)
NYSE Market Open
Alcon Inc. is a global eye care company serving both the vision care and ophthalmic surgery markets. Formerly part of Novartis, it became an independent public company in 2019 and now operates as one of the most recognizable names in products used to correct, protect, and improve eyesight. Its business is built around long-term demand for eye health solutions driven by ageing populations, rising rates of myopia, and continued innovation in surgical and contact lens technologies.
The vision care segment includes daily and reusable contact lenses, lens care solutions, and ocular health products. Alcon’s contact lens brands include Dailies, Total1, and Air Optix, which compete across premium and mass-market categories. The company also sells products aimed at dry eye relief, allergy care, and general eye wellness, giving it a broad presence in optometry and retail channels.
Alcon’s surgical segment supplies equipment, implantable lenses, and consumables used by ophthalmologists. Its portfolio includes phacoemulsification systems for cataract surgery, such as Centurion, along with intraocular lenses including PanOptix and Vivity. These products support procedures that restore or improve vision, particularly cataract operations, one of the most common surgical categories worldwide.
A key strength of Alcon is its large installed base of surgical equipment, which can create recurring demand for consumables, service, and related products. The company competes in markets where brand trust, clinical performance, surgeon familiarity, and regulatory approvals matter. Its position combines consumer-facing vision products with specialized medical technology used in operating rooms.
Last updated
- Market Cap
- 31.32B
- P/E
- 71.18
- P/FCF
- —
- P/S
- 3.65
- Enterprise Value
- 34.26B
- Sector
- —
- Industry
- —
- Address
- —
National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others
2026 DallasCISO ORBIE Awards Recognize Top Security Executives
LENSAR® Provides Update on Pending Acquisition by Alcon
Contact Lens Market Size to Hit USD 26.64 Billion by 2033, Driven by Rising Vision Care Awareness and Technological Advancements – SNS Insider
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider
Global Surgical Microscopes Market to Surpass USD 2.59 Billion by 2030 | MarketsandMarkets™
Global Cataract Surgery Devices Market to Grow at a CAGR of ~5% Driven by Innovation and Increasing Patient Awareness | DelveInsight
LENSAR Reports Second Quarter 2025 Results and Provides Business Update
Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction
U.S. Ophthalmic Photocoagulator Growth Trends and Forecasts 2025-2032 - Market Expands Amid Surge in Diabetic Retinopathy Cases
Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight
Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica
Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities
Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge
Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type
Ophthalmic Lasers Market Forecast Report to 2029: Key Trends Include Growing Popularity of Femtosecond Lasers in Ophthalmic Surgery and Growing Preference for Minimally Invasive Ophthalmic Procedures
Ocular Prosthesis Market Trends, Challenges and Opportunities to 2030: A Projected $2.3 Billion Landscape
Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer
Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030
Ophthalmology Devices Market Analysis Report 2025-2030: Industry Trends, Market Shares and Competitive Strategies
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 31.32B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 34.26B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 71.18
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.6
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.65
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 32.2
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.99
- EPS
- 0.9
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 2.25%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.59%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.2
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.16
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.31
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.44
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 2.43M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 64.22
Income Statement
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 2.22B |
| Gross profit | — | — | — | — | 1.2B |
| Operating income | — | — | — | — | 200M |
| EBITDA | 0 | 0 | 0 | 0 | 200M |
| Net income | — | — | — | — | 148M |
| Basic EPS | — | — | — | — | 0.3 |
| Diluted EPS | — | — | — | — | 0.3 |
Balance Sheet
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|
| Total assets | 31.56B | 30.35B | 29.61B | 29.17B | 27.73B |
| Total liabilities | 9.52B | 8.79B | 8.99B | 9.49B | 8.19B |
| Total equity | 22.04B | 21.55B | 20.62B | 19.68B | 19.54B |
| Cash & equivalents | 1.53B | 1.68B | 1.09B | 980M | 1.03B |
| Current assets | 6.37B | 6.16B | 5.65B | 5.19B | 5.02B |
| Current liabilities | 3.05B | 2.28B | 2.4B | 2.74B | 2.32B |
Cash Flow
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | — |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Change in cash | — | — | — | — | — |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 20-F — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | DFAN14A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | DFAN14A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | DEFM14A — ALCON INC | View Filing | |
| edgar index | SD — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SCHEDULE 13G/A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | DFAN14A — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 20-F — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | SD — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 20-F — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SC 13G — ALCON INC | View Filing | |
| edgar index | SC 13G/A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SD — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 144 — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 20-F — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | IRANNOTICE — ALCON INC | View Filing | |
| edgar index | SC 13G — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SC 13G/A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SC 13G — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | DEFA14A — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | SD — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 6-K — ALCON INC | View Filing | |
| edgar index | 20-F — ALCON INC | View Filing |